(410 ILCS 620/3.12)
(from Ch. 56 1/2, par. 503.12)
The using on the labeling of any drug or device or in any advertisement
relating to such drug or device of any representation or suggestion that an
application with respect to such drug is effective under Section 17 or
that such drug or device complies with the provisions of such Section.
(Source: P.A. 84-891.)